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LETTER TO THE ED ITOR 
Further Evidence For Ultraviolet Light Induction 
Of CDKN2 (p16INK4) Mutations In Sporadic 
Melanoma In Vivo 
To the Edito r: 
We wou ld like to suppl ement the recently pub lished finding of a 
CC to TT mutation at codons 57/58 of the CDKN2 (P16 INK4 ) gene 
in a sporad ic me lan om a (Healy el aI, 1996). T he tumor reported 
showed loss of one a ll e le (loss of heterozygosity, LOH) of the 
region on chromosome 9 (9p21) that harbo rs CDKN2, which 
wo uld then be consisten t w ith bi-a ll e li c inactivation of the gene. 
Furthenn o re, the mutation pattern of a CC to TT trans iti on 
stl·o ngly suggests ultrav io let ligh t as the ca usative agent (Maestro 
and Boiocchi, 1995) . 
We seq uenced the entire coding reg io n of CDKN2 of tumor 
tissue (s ix primal·y melanomas and six metas tatic tum o rs) fi·om 12 
difFerent melanoma patients with sporadic melanoma by dj rect 
polym e rase chain reaction-based cycle sequen cin g and detected 
o nly one mutation [in a metastatic tumor of an initiall y nodular 
melanoma, tum or thi ckness (Breslow) 4.2 mm, C lark level IV, 
stage lIB (AJCC/U ICC, 1988)]: a CC to TT mutation in ex on 2 at 
codon 100 (Fig 1), wh ich alters an alan ine to a va lin e . Correspond-
ing "normal" tissue (from periphera l blood lymph ocytes) showed 
w ild-type seq uencc for CDKN2. 
T hi s mutation would also altcr a recently described altemative 
traoscrip t (f3- tran script) (Mao e{ aI, 1995; Que ll e ei aI, 1995; Stone 
el aI, 1995): positions mutated iJl this case wo uld be 483 and 484 
aftecting codon 162 and alte rin g an arginin e (CCG) to <1 le ucine 
(TTG) if open readi.ng frame 2 was u ti lized. 
Testing for loss of heterozygosity of th e chro mosom al region in 
the vicinity of CDKN2 on 9p2 ·l by microsatelli te repeat anal ys is 
using sta ndard procedures revea led retained heterozygosity at 
m arkers D9S·126, I FNA, and D9S598, the latter being located 
approximate ly 16 kb te lomeric of CDKN2 (Herbst el aI, 1994). 
O ne exp lanation consistent w ith these results would be a de letion 
of the second aUele too small to be detected by the markers used. 
Altcmatively, gene con version may have taken place, resulting in the 
presence of two copies of the mutated gene in the clonal tumor cdl 
population. Finall y, whi le the occurrence of two independent identical 
mutations cannot be ruled out, thi s secm s unljke ly. 
T he possib le ca usative ro le of ul.trav io let light in melanoma 
indu ctio n is underscored by this partic ular mutation pattern. To 
date, the vast majority of CDKN2 mutations reported-includin g 
the prcsumably ulta violet light-induced m utations-come fr0111 
cell lines (Luca el aI, 1995; Pollock cf aI, 1996) . T he detec tio n of 
these genetic chan ges on the molecular level ;1/ 1) ;1)0 supports these 
fi ndings and the large body of epidemio logic ev idence that point to 
a "sunligh t etio logy" of melanoma. 
Manllscrip t received September 30, 199(>; revised December 19. 1996; 
accepted for publication February 28, 1997. 
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Figure 1. CC to TT tandCln base mutation in exon 2 at codon 100 
of CDKN2 (p16INK4). DNA sequence of tumor (T) and corresponding 
no nnal (NL) tissues of a rn c tastati c rnClallOJlla. 
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